Symbol
| ACHE
| contributors: mlc/npt/pgu - updated : 19-09-2023
|
HGNC name
| acetylcholinesterase (Yt blood group)
|
HGNC id
| 108
|
corresponding disease(s)
|
YT
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --low
|  
|
in Alzheimer disease (AD) decrease in the enzymatic activity of the enzyme acetylcholinesterase | |
Susceptibility
|
to neurodegenerative diseases |
Variant & Polymorphism
other
| variants putatively involved in neurodegenerative diseases |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
neurology | neurodegenerative | alzheimer | |
AChE) enzyme inhibition is an important target for the management of Alzheimer disease (AD) and ACHE inhibitors are the main stay drugs for its management | neurology | neurodegenerative | alzheimer | |
Acetylcholinesterase (AChE) has obtained a renewed interest as a therapeutic target in Alzheimer's disease (AD) due to increased neural cells' function by increasing the concentration of acetylcholine |
| | | |
| significant decrease in trabecular perimeter of lumbar vertebrae and cortical area fraction (Ct.Ar/Tt.Ar) in the mid-diaphysis of femurs of AChE-KO mice compared to their WT |